1887
Volume 2022 Number 1
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Acute coronary syndrome (ACS) is one of the most common life-threatening diseases worldwide.1 Early diagnosis, advanced cardiac life support, and rapid transportation to a cardiac center are essential to reduce mortality and morbidity. ST-segment elevation myocardial infarctions (STEMI) are life-threatening and are diagnosed with a 12-lead electrocardiogram (ECG). However, non-STEMI (NSTEMI) is not prioritized as a STEMI in the prehospital setting. Studies have confirmed that patients who are diagnosed with an ACS in the prehospital setting are more likely to survive.2,3 A scoping review was conducted based on the above topic. Limited data is available on prehospital cardiac troponin tests for NSTEMI. Paramedics from the national Ambulance Service in Qatar diagnose patients with ACS based on the findings of a 12-lead ECG, clinical presentation, abnormalities in vital signs, physical examination, and congruent history which is compatible with the American Heart Association and European Resuscitation Council recommendations. In a case of NSTEMI chest pain, the paramedic cannot rule out Acute Myocardial Infarction (AMI), yet the patient will be taken to the normal emergency department until further investigations are done.1 ACS remains a challenge to diagnose in the prehospital setting as the diverse population in Qatar makes communication often difficult which would negatively impact the patient's assessment. Although the accuracy of prehospital Troponin tests done around 2010 was relatively encouraging2, their sensitivity has now significantly improved and warrants further studies to highlight their benefit to patient care.3 The routing of patients with ACS (STEMI and NSTEMI) to the appropriate cardiac center is essential to assure they receive a rapid diagnosis and appropriate care. The enhanced diagnostic accuracy of ACS in the prehospital setting by using a rapid Troponin test is expected to accelerate the care of NSTEMI patients and should be explored in Qatar. This scoping review indicates that limited data is available on cardiac troponin tests for NSTEMI.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2022.qhc.61
2021-11-30
2022-09-30
Loading full text...

Full text loading...

References

  1. Mechanic OJ, Grossman SA, 2020. Acute Myocardial Infarction. StatPearls Publishing, FL. https://www.ncbi.nlm.nih.gov/books/NBK459269/(Accessed: 26 July 2021).
    [Google Scholar]
  2. Sørensen JT, Terkelsen CJ, Steengaard C, Lassen JF, Trautner S, Christensen EF, Nielsen TT, Bøtker HE, Andersen HR, Thygesen K. Prehospital troponin T testing in the diagnosis and triage of patients with suspected acute myocardial infarction. The American journal of cardiology. 2011 May 15; 107:(10):1436–40.
    [Google Scholar]
  3. Martín-Rodríguez F, Sanz-García A, Castro-Portillo E, Delgado-Benito JF, del Pozo Vegas C, Ortega Rabbione G, Martín-Herrero F, Martín-Conty JL, López-Izquierdo R. Prehospital troponin as a predictor of early clinical deterioration. European Journal of Clinical Investigation. 2021 May 18:e13591.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2022.qhc.61
Loading
  • Article Type: Conference Abstract
Keyword(s): Acute Myocardial Infarctionchest painElectrocardiogramPrehospital and Troponin

Most Cited This Month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error